Clinical trial
Treating Amblyopia With CureSight
NCT06165705 is registered in ClinicalTrials.gov with Alaska Blind Child Discovery as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treating Amblyopia With CureSight
- Lead sponsor
- Alaska Blind Child Discovery
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 1, 2023
- Completion date
- December 31, 2025
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.